Antidote Treatment - Nerve Agent, Auto-Injector (ATNAA) [2.1 mg atropine and 600mg pralidoxime (2-PAM)]; Convulsant Antidote for Nerve Agent (CANA) [10mg diazepam]; Advanced Anticonvulsant System (AAS) [10mg midazolam]; Rapid Opioid Countermeasure System (ROCs) [10mg naloxone]

1May be variable due to agent characteristics, exposure dose, individual response variability, PPE worn at time of exposure, and whether antidotes administered.

2May be variable due to agent characteristics, exposure dose, individual response variability, PPE worn at time of exposure, and whether anticholinergics administered.

3ROCS (naloxone) does not have any significant drug interactions with the drugs contained in ATNAA, CANA or AAS.

4Depending on the agent and dose there may be convulsions.

5If wearing PPE may be diaphoretic.

6Reference ATP 4-02.85/MCRP 4-11.1A/NTRP 4-02.22/AFTTP(I) 3-2.69 for nuances of self-aid, buddy aid, combat lifesaver care, or treatment by the combat medic/corpsman/Air Force medic.